Yahoo Web Search

  1. Here’s What Hedge Funds Think About Aerie Pharmaceuticals Inc (AERI)

    Insider Monkey via Yahoo FinanceMay 02 16:42 PM

    We will study how this market volatility affected their sentiment towards Aerie Pharmaceuticals Inc (NASDAQ:AERI) during the quarter below.

  2. What's in Store for Catalyst Pharma (CPRX) Q1 Earnings?

    Zacks via Yahoo FinanceMay 03 13:51 PM

    This is because a stock needs to have a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below. Earnings ESP: Catalyst Pharma has an Earnings ESP of 0.00%.

  3. BioDelivery Sciences International, Inc. BDSI is scheduled to report first-quarter 2019 results on May 6 after market close. In the last reported quarter, the company’s earnings were in line with the Zacks Consensus Estimate.

  4. Endo (ENDP) Q1 Earnings & Revenues Beat Estimates

    Zacks via Yahoo FinanceMay 10 18:41 PM

    Branded - Sterile Injectables segment and the Specialty Products portfolio of Branded Pharmaceuticals segment. Quarterly Highlights Endo has four reportable business segments — ...

  5. The biotech company developing therapies and food to treat metabolic dysregulation in the liver is to list its shares on the Nasdaq under the ticker symbol AXLA. Cortexyme, which develops a ...

  6. BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat

    Zacks via Yahoo FinanceMay 07 13:40 PM

    BioDelivery Sciences International, Inc. BDSI incurred a loss of 5 cents per share for first-quarter 2019, narrower than the Zacks Consensus Estimate of a loss of 8 cents. The top line ...

  7. Edited Transcript of PGNX earnings conference call or presentation 9-May-19 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 15 6:33 AM

    At the ENDO meeting in March, there was a well attended oral session dedicated to pheo and para, which highlighted AZEDRA...? --------------------------------------------------------- ...

  8. Federal jurors in Boston found that Kapoor conspired with four other executives to bribe doctors to pump up sales of Subsys and duped insurers into covering shady prescriptions. Former vice ...

  9. Edited Transcript of ENDP earnings conference call or presentation 9-May-19 11:30am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 15 4:55 AM

    Moving to our CCH development program for assessing the treatment of cellulite...submission with a target market launch in the second half of 2020, subject to FDA approval. As part of our plan ...

  1. Ads
    related to Endo Pharmaceuticals Inc